Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Clinical trial NCT06485232 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06485232
Sponsor: Xuanwu Hospital, Beijing
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorders Myasthenia Gravis, Generalized Multiple Sclerosis Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Start date: 2025-02-28
Primary completion: 2026-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.